TP53 and B-cell chronic lymphocytic leukemia: In sum, our finding of an independent prognostic value of TP53 mutations, not detectable by conventional techniques in a subset of patients lacking treatment indication at baseline, adds another cobblestone to the positioning of amplicon deep-sequencing assays in established CLL diagnostics algorithms.